C

Corbus Pharmaceuticals Holdings

D
CRBP
USD
-0.58
(-3.1974%)
Market Closed
6,949.00
حجم التداول
-3.77
الربح لكل سهم
-
العائد الربحي
-3.032815
P/E
211,491,586.40
حجم السوق
اليوم
-3.1974%
1 اسبوع
-5.388%
1 شهر
-6.197%
6 اشهر
-59.144%
12 اشهر
365.166%
بداية السنة
174.804%
كل الوقت
-91.392%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Corbus Pharmaceuticals Holdings

Sector:
Healthcare
Industry:
Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
هل تحتاج مساعدة او لديك استفسار؟